dipivefrin and Active Hyperemia
dipivefrin has been researched along with Active Hyperemia in 3 studies
dipivefrin: used in treatment of both primary & open angle glaucoma; RN given refers to (+-)-isomer
dipivefrin : The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect on intraocular pressure (IOP) and aqueous flare of topical applications of latanoprost and dipivefrin alone or combined." | 9.08 | Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. ( Alm, A; Mäepea, O; Widengård, I, 1998) |
| "To investigate the effect on intraocular pressure (IOP) and aqueous flare of topical applications of latanoprost and dipivefrin alone or combined." | 5.08 | Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability. ( Alm, A; Mäepea, O; Widengård, I, 1998) |
| "Dipivefrin hydrochloride is a lipophilic prodrug for epinephrine hydrochloride, allowing lower concentration of the drug to achieve the same intraocular pressure lowering effect and having also less harmful effects than epinephrine hydrochloride." | 1.29 | Corneal vascularization and opacification during long-term use of dipivefrin. ( Hakala, T; Helin, H; Krootila, K; Salminen, L, 1995) |
| "1%) developed adverse external ocular side effects severe enough to require that the drug be discontinued." | 1.26 | External ocular toxicity of dipivalyl epinephrine. ( Leibowitz, HM; Theodore, J, 1979) |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Salminen, L | 1 |
| Krootila, K | 1 |
| Helin, H | 1 |
| Hakala, T | 1 |
| Widengård, I | 1 |
| Mäepea, O | 1 |
| Alm, A | 1 |
| Theodore, J | 1 |
| Leibowitz, HM | 1 |
Trials
1 trial available for dipivefrin and Active Hyperemia
| Article | Year |
|---|---|
Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.
Topics: Adrenergic Agonists; Aged; Blood-Aqueous Barrier; Conjunctival Diseases; Drug Administration Schedul | 1998 |
Other Studies
2 other studies available for dipivefrin and Active Hyperemia
| Article | Year |
|---|---|
Corneal vascularization and opacification during long-term use of dipivefrin.
Topics: Blepharitis; Conjunctival Diseases; Corneal Neovascularization; Corneal Opacity; Epinephrine; Female | 1995 |
External ocular toxicity of dipivalyl epinephrine.
Topics: Administration, Topical; Aged; Conjunctiva; Conjunctivitis; Drug Tolerance; Epinephrine; Eye Disease | 1979 |